omega-n-methylarginine has been researched along with eprosartan in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (eprosartan) | Trials (eprosartan) | Recent Studies (post-2010) (eprosartan) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 297 | 83 | 49 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | eprosartan (IC50) |
|---|---|---|---|
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 6.65 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1244 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1244 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delles, C; Fleischmann, I; Jacobi, J; John, S; Schmieder, RE | 1 |
1 trial(s) available for omega-n-methylarginine and eprosartan
| Article | Year |
|---|---|
Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Topics: Acrylates; Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Vessels; Double-Blind Method; Drug Combinations; Enalapril; Enzyme Inhibitors; Hemodynamics; Humans; Hypertension; Imidazoles; Male; Nitric Oxide; omega-N-Methylarginine; Receptor, Angiotensin, Type 1; Renal Circulation; Thiophenes | 2002 |